Article Details

Ahead Of AdComm AstraZeneca, FibroGen's Roxadustat Hit With Safety, Efficacy Questions

Retrieved on: 2021-07-13 17:03:45

Tags for this article:

Click the tags to see associated articles and topics

Ahead Of AdComm AstraZeneca, FibroGen's Roxadustat Hit With Safety, Efficacy Questions. View article details on HISWAI: https://finance.yahoo.com/news/ahead-adcomm-astrazeneca-fibrogens-roxadustat-170315409.html

Excerpt

... the agency is raising fresh doubts on the safety of AstraZeneca Plc's (NASDAQ: AZN) and FibroGen Inc's (NASDAQ: FGEN) anemia drug roxadustat.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up